Department of Gastroenterology, Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
Location status: Recruiting
NCT Number: NCT05735678
Flexible endoscopes are used globally for the diagnosis and treatment of diseases of the GI tract. Duodenoscopes used for Endoscopic Retrograde Cholangiopancreatography (ERCP), in order to treat different biliary and pancreatic disorders, have been recently linked to infections transmission following the procedures. Given their reusability and their complex design of the tip with a moving metallic component, named the "elevator", these instruments must be reprocessed through high level disinfection (HLD) in order to prevent the spread of nosocomial infections. Even strict adherence to all HLD procedures results in a residual level of potentially infectious microbes. In fact, the United States Food and Drug Administration (FDA) postmarket surveillance communication reported duodenoscope culture results demonstrating contamination rates of up to 3.6% for low and moderate-concern organisms and up to 5.4% for high-concern organisms in reprocessed conventional duodenoscopes. As a consequence, at least 20 outbreaks of duodenoscope-transmitted multidrug resistant organism (MDRO) infections occurred between 2012 and 2015, despite reported compliance with duodenoscope reprocessing guidelines. The increasing concern that currents practices of reprocessing reusable duodenoscopes is insufficient, has led the FDA to released recommendation suggesting to develope a newly designed duodenoscopes. On one hand, a way is to generate duodenoscope with disposable components, such as a one-use end cap, which can be removed and allow access to the components of the elevator and other areas of the duodenoscope for reprocessing. On the other hand, an alternative is to produce a fully disposable single-use duodenoscope. The evident advantage of a single use duodenoscope, over disposable components, is that it completely eliminates the need for reprocessing and more important the risk of transmitting microbial infection from patient to patient.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rozzano, Milano, 20089, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single-Use Duodenoscopes
Time frame: 24 months
Time frame: 24 months
Contact information is provided by the study sponsor or research team.
Alessandro Fugazza, MD
CONTACT
Alessandro Repici, MD
CONTACT
Istituto Clinico Humanitas
Other
Acronym: SUSPECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06598943
Colitis, Colitis, Ulcerative
Chandler, Arizona, United States
View Trial DetailsNCT06478823
Digestive System Diseases, Gastro-Intestinal Disorder
Paris, France
View Trial DetailsNCT07377487
Adenocarcinoma, Carcinoma
Nishinomiya, Hyōgo, Japan
View Trial DetailsNCT07222800
Colonic Diseases, Colonic Neoplasms
Chandler, Arizona, United States
View Trial Details